Linked from

The 14 pages that link to Implantable cardioverter-defibrillator, each with the reason it gives.

• Sudden cardiac deathRelated: It prevents some deaths in people at high risk of recurrent lethal arrhythmias.

• Hypertrophic cardiomyopathyRelated: It can prevent sudden cardiac death in patients judged to have substantial arrhythmic risk.

• Ventricular fibrillationRelated: It can prevent death from recurrent ventricular fibrillation in selected high-risk patients.

• Long QT syndromeRelated: It is considered for selected patients who remain at high risk despite medical treatment.

• Ventricular tachycardiaRelated: It can terminate sustained ventricular tachycardia and reduce sudden-death risk in selected patients.

• CardiomyopathyRelated: Some cardiomyopathies increase sudden-death risk enough to warrant device therapy.

• Dilated cardiomyopathyRelated: Selected patients may receive one to reduce risk of sudden cardiac death.

• Heart failure with reduced ejection fractionRelated: It prevents sudden arrhythmic death in selected patients whose risk remains high.

• ArrhythmiaRelated: It can prevent sudden death in people at high risk of life-threatening ventricular arrhythmias.

• Brugada syndromeRelated: It is considered for Brugada patients at high risk of sudden cardiac death.

• Earl BakkenRelated: It represents a later expansion of implantable electronic treatment for cardiac rhythm disorders.